January 10, 2017 / 11:30 AM / 7 months ago

BUZZ-Valeant Pharmaceuticals: To sell Danderon cancer business, 3 skincare brands

1 Min Read

** Canadian drugmaker's U.S.-listed shares up 14.33 pct at $17.55 premarket

** French cosmetics group L'Oreal is acquiring three specialized skincare brands - CeraVe, AcneFree and Ambi - from Canada's Valeant Pharmaceuticals for $1.3 billion in cash to expand into one of the fastest growing areas of the beauty industry

** Valeant said on Monday its affiliate will sell its Dendreon cancer business to China's Sanpower Group Co Ltd for $819.9 million, as the drugmaker continues to shed non-core assets to repay debt

** Company's stock lost 85.71 pct of its value in 2016

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below